0001209191-20-052780.txt : 20201001
0001209191-20-052780.hdr.sgml : 20201001
20201001200008
ACCESSION NUMBER: 0001209191-20-052780
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200929
FILED AS OF DATE: 20201001
DATE AS OF CHANGE: 20201001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOBULSKY SUSAN
CENTRAL INDEX KEY: 0001820885
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 201217763
MAIL ADDRESS:
STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION
STREET 2: 1551 EASTLAKE AVE E STE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp
CENTRAL INDEX KEY: 0001478320
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270907024
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-659-0067
MAIL ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptive TCR Corp
DATE OF NAME CHANGE: 20091209
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-29
0
0001478320
Adaptive Biotechnologies Corp
ADPT
0001820885
BOBULSKY SUSAN
C/O ADAPTIVE BIOTECHNOLOGIES CORP.
1551 EASTLAKE AVE E STE 200
SEATTLE
WA
98102
0
1
0
0
SVP, Diagnostics, clonoSEQ
Common Stock
2020-09-29
4
M
0
10000
1.98
A
10000
D
Common Stock
2020-09-29
4
S
0
10000
50.00
D
0
D
Stock Option (Right to Buy)
1.98
2020-09-29
4
M
0
10000
0.00
D
2024-10-13
Common Stock
10000
55000
D
These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019.
All options are fully exercisable.
Susan Bobulsky by Eric Billings, attorney-in-fact
2020-10-01